Curis (CRIS) Gross Profit Growth (3y) (2015 - 2025)
Curis (CRIS) Gross Profit Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 77.42% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 28.75% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 45.27% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 59.77% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -45.72% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 80.79% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.69% |
| Sep 30, 2025 | 4.59% |
| Jun 30, 2025 | 5.15% |
| Mar 31, 2025 | 6.21% |
| Dec 31, 2024 | 3.77% |
| Sep 30, 2024 | 0.24% |
| Jun 30, 2024 | 5.30% |
| Mar 31, 2024 | -0.66% |
| Dec 31, 2023 | -3.12% |
| Sep 30, 2023 | 2.08% |
| Jun 30, 2023 | -1.74% |
| Mar 31, 2023 | -4.18% |
| Dec 31, 2022 | -3.95% |
| Sep 30, 2022 | 0.64% |
| Jun 30, 2022 | 5.45% |
| Mar 31, 2022 | 5.98% |
| Dec 31, 2021 | 5.01% |
| Sep 30, 2021 | 2.36% |
| Jun 30, 2021 | -0.82% |
| Mar 31, 2021 | -3.84% |